Remicade Side Effects. This month, the Food and Drug Administration (FDA) announced that it is approving the use of Remicade (generic name: infliximab) to treat ulcerative colitis (UC) among children aged 6 years old and older “who have had inadequate response to conventional therapy.”
Says Donna Griebel, M.D., director of the Division of Gastroenterology and Inborn Errors Products in the FDA’s Center for Drug Evaluation and Research:
With the approval of Remicade, children with moderately to severely active ulcerative colitis who have not had an adequate response to conventional treatment now have an FDA-approved treatment option. However, there are serious risks associated with its use. Patients and their families should always discuss with their physician the risks and benefits of using a medication before deciding to start treatment.
Continue reading Remicade Side Effects: Headache, Infections, Ulcerative Colitis